Are These 5 Biotech Penny Stocks Worth Watching?
With the extraordinary times we live in, Covid has resulted in a large investor focus on biotech penny stocks. Within the stock market, there’s no shortage of interesting biotech companies to choose from. In 2021, it’s best to divide biotech penny stocks into ones working on a covid-treatment and ones that aren’t. While neither of these will help to avoid volatility, this is a good way to break up one’s research as vaccine headlines tend to enhance volatility in certain circumstances.
Speculation has always been a major pull for investors. One thing to keep in mind is that whether a company has a medical device or breakthrough pharmaceutical, it will need to be approved by the FDA. This process can take years and involves a great deal of capital. With this, investors should know the ins and outs of the company they plan to invest in. This lengthy process can be a tool for both investors & day traders to use. Each phase update, trial initiation, interim data announcement, etc. can act as its own catalyst.
Heading into the second full week of March, hopes are high that the markets begin turning around. For biotech penny stocks, in particular, this week could be an active one as several industry conferences are set to commence. Companies will be presenting data and giving presentations on their pipelines.
In particular, the Chardan Microbiome Medicines Summit kicks things off on Monday, with H.C. Wainwright’s Global Life Sciences & Barclays Global Healthcare Conference carrying through the remainder of the week until the 11th. We’ve also got a slew of biotech earnings to track, which could also highlight the broader industry. With this in mind, let’s take a look at 5 biotech penny stocks to watch as markets attempt to recover this week.
Biotech Penny Stocks to Watch This Week
- Iterum Therapeutics PLC (NASDAQ: ITRM)
- Acasti Pharma Inc. (NASDAQ: ACST)
- SINTX Technologies Inc. (NASDAQ: SINT)
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
- Anchiano Therapeutics (NASDAQ: ANCN)
Penny Stocks To Watch #1: Iterum Therapeutics PLC
Iterum Therapeutics is a clinical-stage pharmaceutical company. It works on producing anti-infectives to help solve drug-resistant pathogenic illnesses. Right now, its most notable substance is known as sulopenem. This is a novel compound that can be used either intravenously or orally and is currently in Phase 3 clinical trials to see if it can be more effective than traditional antibiotics.
Additionally, the company has received a Qualified Infectious Disease Product and Fast Track designation for seven indications related to sulopenem. Iterum plans to release its fourth-quarter financial results on March 12th during pre-market. Ahead of this, let’s take a closer look at what ITRM is up to right…